Want to see CNC full AI Analyst Report?
CNC Stock Chart & Stats
$38.17
$0.57(0.91%)
At close: 4:00 PM EST
$38.17
$0.57(0.91%)
Day’s Range― - ―
52-Week Range$25.08 - $66.55
Previous CloseN/A
Volume1.00M
Average Volume (3M)5.55M
Market Cap
$31.70B
Enterprise Value$25.05B
Total Cash (Recent Filing)$23.74B
Total Debt (Recent Filing)$16.37B
Price to Earnings (P/E)―
Beta0.37
Next Earnings
Jul 28, 2026EPS Estimate
1.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.12
Shares Outstanding493,797,000
10 Day Avg. Volume6,355,587
30 Day Avg. Volume5,546,709
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.01
Price to Sales (P/S)0.10
P/FCF Ratio4.68
Enterprise Value/Market Cap0.79
Enterprise Value/Revenue0.13
Enterprise Value/Gross Profit0.85
Enterprise Value/Ebitda-5.64
Forecast
1Y Price Target
$60.29Price Target Upside57.96% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
EPS Forecast (FY)3.5
Revenue Forecast (FY)$191.12B
Bulls Say, Bears Say
Bulls Say
Government-backed Revenue ScaleCentene’s large, government-contracted Medicaid/Medicare and Marketplace footprint creates durable, recurring premium flows and scale advantages. That scale supports negotiating leverage with providers, diversified state contracts, and predictable premium receipts that underpin operations and long-term cash stability.
Strong Cash Generation And Free Cash FlowRobust operating and free cash flow provide durable financial flexibility to fund working capital, invest in care management and pay down or refinance debt. Positive cash flow despite accounting losses offers operational resilience and resources for liability management and program investments over coming quarters.
Operational Execution And Leadership RefreshManagement raised guidance and tightened SG&A while highlighting scaled trend-management programs and leadership realignment. Improved operational discipline and refreshed senior roles signal stronger execution capacity to control costs and improve margins across segments over the medium term.
Bears Say
Recent Profitability DeteriorationA swing to meaningful net losses and negative returns on equity erodes capital cushions and regulatory surplus over time. Persistent unprofitability would reduce financial flexibility, pressure reserves and capital ratios, and require sustained margin recovery to restore long-term earnings quality and investor confidence.
Elevated Medical And Specialty Pharmacy TrendsElevated utilization and specialty drug costs are structural margin headwinds that can persist beyond one or two quarters. These cost trends increase medical loss ratios and complicate pricing for government programs, making durable margin improvement dependent on effective utilization management and payment integrity execution.
Marketplace Visibility And Risk-adjustment RelianceMaterial reliance on June Wakely risk/claims data to confirm risk-adjustment receivables creates sustained uncertainty in Marketplace underwriting and embedded margins. Until verified, guidance may understate downside risk and underwriting remains exposed to membership mix and lagged settlement mechanics.
Centene News
CNC FAQ
What was Centene’s price range in the past 12 months?
Centene lowest stock price was $25.07 and its highest was $66.55 in the past 12 months.
What is Centene’s market cap?
Centene’s market cap is $31.70B.
When is Centene’s upcoming earnings report date?
Centene’s upcoming earnings report date is Jul 28, 2026 which is in 27 days.
How were Centene’s earnings last quarter?
Centene released its earnings results on Apr 28, 2026. The company reported $3.37 earnings per share for the quarter, beating the consensus estimate of $2.228 by $1.142.
Is Centene overvalued?
According to Wall Street analysts Centene’s price is currently Undervalued.
Does Centene pay dividends?
Centene does not currently pay dividends.
What is Centene’s EPS estimate?
Centene’s EPS estimate is 1.06.
How many shares outstanding does Centene have?
Centene has 493,797,000 shares outstanding.
What happened to Centene’s price movement after its last earnings report?
Centene reported an EPS of $3.37 in its last earnings report, beating expectations of $2.228. Following the earnings report the stock price went up 13.954%.
Which hedge fund is a major shareholder of Centene?
Currently, no hedge funds are holding shares in CNC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Centene Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$60.29 (57.96% Upside)
$60.29 (57.96% Upside)
Blogger Sentiment
Bullish
CNC Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 145.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $5.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.1%
Last 30 Days ▲ 6.4%
Last 30 Days ▲ 6.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
19.54%
12-Months-Change
Fundamentals
Return on Equity
-28.72%
Trailing 12-Months
Asset Growth
-6.74%
Trailing 12-Months
Company Description
Centene
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
CNC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong first-quarter execution with an EPS beat, raised full-year EPS outlook, improved Medicaid margins, Medicare outperformance, disciplined SG&A and robust cash generation. These positives were balanced by ongoing elevated medical and specialty pharmacy trends, Marketplace utilization in the Silver tier (with guidance conservatively not reflecting the full potential risk adjustment offset), seasonality that weights earnings toward Q1 and the need to refine assumptions once June Wakely data arrives. Management emphasized operational progress (trend programs, payment integrity, leadership changes) and prudent conservatism in guidance.View all CNC earnings summariesCNC Revenue Breakdown
88.08% Premium
1.55% Service
10.37% Premium tax
CNC Stock 12 Month Forecast
Average Price Target
$60.29
▲(57.96% Upside)
Technical Analysis
Ownership Overview
0.76% Insiders
22.18% Mutual Funds
21.60% Other Institutional Investors
27.34% Public Companies and Individual Investors